It might benefit patients with ATXN2 mutation because TDP-43 aggregation is a component of nearly all cases of ALS and TDP-43 localization to ATXN2-dependent stress granules is a shared pathologic endpoint. Here, ATXN2 is linked to amyotrophic lateral sclerosis.